NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Register

ADVERTISEMENT

ADVERTISEMENT

New HSE resources for both type 1 and type 2 diabetes

By Priscilla Lynch - 09th Sep 2024

type 1 and type 2 diabetes

The HSE has launched an updated clinical guideline for type 1 diabetes and an updated model of care for type 2 diabetes

The  HSE recently launched an updated National Clinical Guideline (NCG) for adults with type 1 diabetes (NCG No 17) to replace the original version published in June 2018.

The updated guideline was developed by the original Guideline Development Group (GDG), supported by the HSE National Clinical Programme for Diabetes (NCPD). The GDG for the 2024 Rapid Update was chaired by Dr Kevin Moore, Consultant Endocrinologist, with support from the HSE NCPD Lead, Prof Derek O’Keeffe.

Part of the process of developing this guideline involved contextualising (for Ireland) the UK’s National Institute for Health and Care Excellence (NICE) NG17 ‘Type 1 diabetes in adults: Diagnosis and management’ guideline, published in 2015, and updated in 2021 and 2022. In 2023, the NCPD decided to update the Irish guideline (NCG No 17) to reflect these changes.

This NCG applies to adults (aged 18 years and older) with type 1 diabetes in Ireland, and does not apply to children living with type 1 diabetes, adults living with type 2 diabetes, or individuals living with monogenic (or other rarer forms of) diabetes. It is relevant to all healthcare professionals working in healthcare settings delivering care to people living with type 1 diabetes in Ireland.

The updated guideline includes recommendations around making continuous glucose monitoring (CGM) available for all adults with type 1 diabetes. The HSE has implemented a reimbursement application system for CGM sensors, since December 2023.

Those recommendations which are new or have been updated can be recognised by the addition of the text [updated 2024] or [new 2024] following each updated or new recommendation. A note on the importance of transitions of care between the paediatric and adult services has also been included. All other text should be read in the context of the original 2018 publication.

Dr Moore said: “The updated national guideline for adults with type 1 diabetes provides a clear plan to ensure that everyone in Ireland has access to high-quality care.”

The full guideline can be accessed at: www.gov.ie/en/collection/2269a-type-1-diabetes-mellitus-in-adults-version-2/

Type 2 diabetes

The HSE has also launched an updated Integrated Model of Care for People with Type 2 Diabetes Mellitus 2024.

The newly-updated integrated model of care was led by Dr Eoin Noctor, Chair of the working group for the integrated model of care for people with type 2 diabetes in collaboration with the NCPD and a large multi-stakeholder working group consisting of people with diabetes, healthcare professionals, academics, and patient advocacy group, Diabetes Ireland.

Dr Noctor said: “It is an exciting time for type 2 diabetes care in Ireland, with major developments over recent years – there has been significant funding allocated for posts to develop integrated care and modernised care pathways, a widespread focus on treatments to prevent and delay type 2 diabetes, and the establishment of the hub model to enhance care of people with type 2 diabetes in the community.”

“This latest model of care for people with type 2 diabetes was a fantastic opportunity to lay out these changes in a single structured format and to build on these developments to clearly set out a road to achieving the highest standards of care for individuals diagnosed with type 2 diabetes. After an extensive discussion-writing process, the consultation group are delighted to see the model of care reach this point and look forward to seeing it implemented with the support of all partners.”

Commenting on both initiatives, Prof O’Keeffe said: “These evidence-based collaborative documents will improve diabetes care in Ireland. I would like to acknowledge the tireless efforts of the entire multidisciplinary working group who contributed to them, including people living with diabetes, advocates, academics, and clinicians, led by our excellent chairs.

“I would also like to sincerely thank all the members of the Diabetes National Clinical Programme.”

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
Medical Independent 8th October 2024
Medical Independent 8th October 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Trending Articles

ADVERTISEMENT